Planning

Welsh Blood Service HbS Testing

  • NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

F01: Prior information notice (prior information only)

Notice identifier: 2025/S 000-003156

Procurement identifier (OCID): ocds-h6vhtk-04d778

Published 30 January 2025, 3:57pm



Section one: Contracting authority

one.1) Name and addresses

NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)

Alder House, Alder Court, St. Asaph Business Park

St. Asaph

LL17 0JL

Email

nwssp.procurementcataloguepathology@wales.nhs.uk

Country

United Kingdom

NUTS code

UK - United Kingdom

Internet address(es)

Main address

http://nwssp.nhs.wales/ourservices/procurement-services/

Buyer's address

https://www.sell2wales.gov.wales/search/Search_AuthProfile.aspx?ID=AA0221

one.2) Information about joint procurement

The contract is awarded by a central purchasing body

one.3) Communication

Additional information can be obtained from the above-mentioned address

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Welsh Blood Service HbS Testing

two.1.2) Main CPV code

  • 71900000 - Laboratory services

two.1.3) Type of contract

Services

two.1.4) Short description

The Welsh Blood Service (WBS) (a division of Velindre University NHS Trust) are looking to appoint a suitably qualified supplier to provide two high performance liquid chromatography (HPLC) analysers to screen approximately 6000 donors per year for HbS.

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKL - Wales

two.2.4) Description of the procurement

The Welsh Blood Service is commissioned by LHBs to be the supplier of blood components for customer hospitals across NHS Wales and plays a fundamental part in the delivery of healthcare in Wales. The Service aims to ensure that the donor’s gift of blood is transformed into safe and effective blood components, which allow NHS Wales to improve the quality of life and save the lives of many thousands of people in Wales every year.

Red cells from those donors with sickle cell trait can be safely transfused into most patients, except those with sickle cell disease (SCD), neonates, and paediatrics, due to the higher risk of red cell sickling, resulting in patient harm.

The Welsh Blood Service are seeking to procure two high performance liquid chromatography (HPLC) analysers (it is envisaged this will be via a Managed Service Contract) to screen approximately 6000 donors per year for HbS in the following cohorts:

- Approximately 5000 whole blood donors selected for neonatal use.

- An additional 1000 units per year, selected for extended phenotypes for Haemoglobinopathies patients.

We invite interested parties to express their interest in this procurement by email to nwssp.procurementcataloguepathology@wales.nhs.uk no later than 17:00hrs Friday 14th February 2025. We aim to hold pre-tender engagement with interested parties by means of either a face to face session or virtually using Microsoft Teams in February/March 2025 to discuss requirements to help shape the specification further.

Please note this engagement is in order to shape a business case, and at this stage does not guarantee that a procurement exercise will follow as this will depend on funding being secured.

two.3) Estimated date of publication of contract notice

1 April 2025


Section four. Procedure

four.1) Description

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes


Section six. Complementary information

six.3) Additional information

NOTE: To register your interest in this notice and obtain any additional information please visit the Sell2Wales Web Site at https://www.sell2wales.gov.wales/Search/Search_Switch.aspx?ID=147758.

(WA Ref:147758)